Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
CN
Home/Newsroom/News

News 2024-03-31

Porton Newsletter | Q1 2024 Recap

Porton PharmaTech (Slovenia)-B31 R&D Labs and Kilo lab Suites (non-GMP), expected to be completed in May 2024.
New Facilities Will Be Ready in Porton USA / J-STAR
Porton's Antibody and ADC GMP Pilot Manufactory Officially Operated
Others
More
Daewoong

News 2026-03-03

Porton Wins “2025 Best CRO” Award from Daewoong Pharma

Daewoong Pharma highly recognized Porton’s contributions to its drug development through active cooperation based on Porton’s excellent capabilities and expertise.
Newsletter

News 2026-02-03

Porton Newsletter - January 2026 Recap

Porton Newsletter - January 2026 Recap
Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200